title: Juvenile myelomonocytic leukemia: molecular pathogenesis informs current approaches to therapy and hematopoietic cell transplantation.
abstract: Juvenile myelomonocytic leukemia (JMML) is a rare childhood leukemia that has historically been very difficult to confidently diagnose and treat. The majority of patients ultimately require allogeneic hematopoietic cell transplantation (HCT) for cure. Recent advances in the understanding of the pathogenesis of the disease now permit over 90% of patients to be molecularly characterized. Pre-HCT management of patients with JMML is currently symptom-driven. However, evaluation of potential high-risk clinical and molecular features will determine which patients could benefit from pre-HCT chemotherapy and/or local control of splenic disease. Furthermore, new techniques to quantify minimal residual disease burden will determine whether pre-HCT response to chemotherapy is beneficial for long-term disease-free survival. The optimal approach to HCT for JMML is unclear, with high relapse rates regardless of conditioning intensity. An ongoing clinical trial in the Children's Oncology Group will test if less toxic approaches can be equally effective, thereby shifting the focus to post-HCT immunomanipulation strategies to achieve long-term disease control. Finally, our unraveling of the molecular basis of JMML is beginning to identify possible targets for selective therapeutic interventions, either pre- or post-HCT, an approach which may ultimately provide the best opportunity to improve outcomes for this aggressive disease.
authors.affiliation: Department of Pediatrics, University of California San Francisco , San Francisco, CA , USA.
authors.forename: Christopher C
authors.initials: CC
authors.lastname: Dvorak
authors.affiliation: Department of Pediatrics, University of California San Francisco , San Francisco, CA , USA.
authors.forename: Mignon L
authors.initials: ML
authors.lastname: Loh
keywords: chemotherapy; hematopoietic cell transplantation; immunotherapy; juvenile myelomonocytic leukemia; minimal residual disease; splenectomy
references.citation: Nature. 2009 Sep 17;461(7262):411-4
references.pmid: 19727076
references.citation: Blood. 2004 Mar 15;103(6):2325-31
references.pmid: 14644997
references.citation: Pediatr Res. 2009 Mar;65(3):334-40
references.pmid: 19047918
references.citation: Blood. 2011 May 5;117(18):4871-80
references.pmid: 21406719
references.citation: Pediatr Transplant. 2013 May;17(3):285-93
references.pmid: 23489519
references.citation: Blood Cancer J. 2013 Nov 15;3:e160
references.pmid: 24241400
references.citation: Ann Hematol. 2012 Apr;91(4):511-7
references.pmid: 21901340
references.citation: Cancer Res. 2013 Apr 15;73(8):2540-50
references.pmid: 23400592
references.citation: Cancer Cell. 2010 Oct 19;18(4):341-52
references.pmid: 20951944
references.citation: Nat Genet. 2006 Mar;38(3):331-6
references.pmid: 16474405
references.citation: Br J Haematol. 2010 Jul;150(1):83-7
references.pmid: 20408841
references.citation: Leukemia. 2005 Jun;19(6):971-7
references.pmid: 15800672
references.citation: Blood. 1997 Jul 15;90(2):479-88
references.pmid: 9226148
references.citation: Br J Haematol. 2003 Jun;121(5):758-67
references.pmid: 12780790
references.citation: Blood. 2013 Jun 13;121(24):4925-9
references.pmid: 23620576
references.citation: Blood. 2013 Sep 19;122(12):2135-41
references.pmid: 23926304
references.citation: Leuk Res. 2009 Mar;33(3):355-62
references.pmid: 18954903
references.citation: Blood. 2011 Nov 17;118(20):5681-8
references.pmid: 21948300
references.citation: Blood. 2009 Mar 19;113(12):2867-8
references.pmid: 19299654
references.citation: Blood. 1990 Nov 1;76(9):1867-71
references.pmid: 2224134
references.citation: Pediatr Transplant. 2008 Dec;12(8):862-7
references.pmid: 18397212
references.citation: Lancet Oncol. 2009 Sep;10(9):855-64
references.pmid: 19695955
references.citation: Biol Blood Marrow Transplant. 2014 Mar;20(3):345-53
references.pmid: 24315842
references.citation: Horm Res. 2009 Dec;72 Suppl 2:8-14
references.pmid: 20029231
references.citation: Blood. 2007 Jun 15;109(12):5477-80
references.pmid: 17332249
references.citation: Br J Haematol. 2012 Jul;158(1):16-29
references.pmid: 22571181
references.citation: Nat Genet. 2003 Jun;34(2):148-50
references.pmid: 12717436
references.citation: Br Med J (Clin Res Ed). 1986 Oct 4;293(6551):839-40
references.pmid: 3094680
references.citation: Bone Marrow Transplant. 2000 Aug;26(4):377-82
references.pmid: 10982283
references.citation: Bone Marrow Transplant. 2004 Jan;33(1):113-5
references.pmid: 14704663
references.citation: Blood. 1997 May 15;89(10):3534-43
references.pmid: 9160658
references.citation: Clin Cancer Res. 2008 Apr 15;14(8):2249-52
references.pmid: 18413813
references.citation: Blood. 2004 Jun 1;103(11):4243-50
references.pmid: 14982883
references.citation: Pediatr Blood Cancer. 2007 Oct 15;49(5):629-33
references.pmid: 16991133
references.citation: Bone Marrow Transplant. 2000 Sep;26(6):681-3
references.pmid: 11041570
references.citation: Pediatr Blood Cancer. 2013 May;60(5):836-41
references.pmid: 23023736
references.citation: J Pediatr Hematol Oncol. 2004 Mar;26(3):190-3
references.pmid: 15125612
references.citation: J Pediatr Hematol Oncol. 2005 Dec;27(12):672-4
references.pmid: 16344675
references.citation: Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16274-9
references.pmid: 20805496
references.citation: J Pediatr Hematol Oncol. 2014 Aug;36(6):491-4
references.pmid: 24322499
references.citation: Nat Genet. 2013 Aug;45(8):937-41
references.pmid: 23832011
references.citation: Nat Genet. 2010 Sep;42(9):794-800
references.pmid: 20694012
references.citation: Am J Hum Genet. 2002 Jun;70(6):1555-63
references.pmid: 11992261
references.citation: Biol Blood Marrow Transplant. 2008 Sep;14(9 Suppl):16-22
references.pmid: 18721776
references.citation: Blood. 2009 Aug 27;114(9):1859-63
references.pmid: 19571318
references.citation: Blood. 2011 Jun 9;117(23):6375-82
references.pmid: 21467544
references.citation: Bone Marrow Transplant. 2007 Sep;40(6):541-7
references.pmid: 17637692
references.citation: J Pediatr Hematol Oncol. 1999 Nov-Dec;21(6):523-7
references.pmid: 10598665
references.citation: Bone Marrow Transplant. 2013 Jun;48(6):825-31
references.pmid: 23222382
references.citation: Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):597-602
references.pmid: 14699048
references.citation: Bone Marrow Transplant. 1998 Jul;22(2):201-3
references.pmid: 9707031
references.citation: Cancer Cell. 2008 Oct 7;14(4):335-43
references.pmid: 18835035
references.citation: J Pediatr. 1997 Jun;130(6):885-9
references.pmid: 9202609
references.citation: J Clin Invest. 2013 Jan;123(1):335-9
references.pmid: 23221337
references.citation: Pediatr Blood Cancer. 2005 Feb;44(2):142-6
references.pmid: 15390271
references.citation: Biol Blood Marrow Transplant. 2008 Jun;14(6):672-84
references.pmid: 18489993
references.citation: Nat Genet. 1996 Feb;12(2):137-43
references.pmid: 8563750
references.citation: J Clin Invest. 2004 Feb;113(4):528-38
references.pmid: 14966562
references.citation: Blood. 2005 Jan 1;105(1):410-9
references.pmid: 15353481
references.citation: Blood. 1991 Mar 1;77(5):925-9
references.pmid: 1704804
references.citation: Blood. 2003 Mar 1;101(5):1713-4
references.pmid: 12393482
references.citation: Bone Marrow Transplant. 2004 Oct;34(8):721-7
references.pmid: 15322568
references.citation: Am J Med Genet A. 2012 Oct;158A(10):2407-11
references.pmid: 22887781
references.citation: Blood. 2011 Feb 10;117(6):2022-32
references.pmid: 21163920
references.citation: Mol Cell. 2000 Jan;5(1):189-95
references.pmid: 10678181
references.citation: Pediatr Blood Cancer. 2013 Jan;60(1):116-20
references.pmid: 22847790
references.citation: Blood. 2008 Feb 1;111(3):1124-7
references.pmid: 18000165
references.citation: Pediatr Blood Cancer. 2008 Oct;51(4):569
references.pmid: 18561174
references.citation: Nat Genet. 1996 Feb;12(2):144-8
references.pmid: 8563751
references.citation: Pediatr Blood Cancer. 2009 Dec 15;53(7):1324-6
references.pmid: 19731324
references.citation: Sci Transl Med. 2011 Mar 30;3(76):76ra27
references.pmid: 21451123
references.citation: Pediatr Transplant. 2005 Dec;9(6):797-800
references.pmid: 16269054
references.citation: Br J Haematol. 2005 May;129(4):542-9
references.pmid: 15877738
references.citation: J Clin Oncol. 2010 Apr 10;28(11):1919-27
references.pmid: 20231685
references.citation: Curr Opin Genet Dev. 2007 Feb;17(1):15-22
references.pmid: 17208427
references.citation: Leuk Res. 2009 May;33(5):671-7
references.pmid: 19010541
references.citation: Blood. 2012 Aug 16;120(7):1485-8
references.pmid: 22753870
references.citation: N Engl J Med. 1994 Dec 22;331(25):1680-4
references.pmid: 7605422
references.citation: Bone Marrow Transplant. 2004 May;33(10):1069
references.pmid: 15064688
references.citation: Br J Cancer. 1994 Nov;70(5):969-72
references.pmid: 7947106